Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis: Induction Treatment With Mitoxantrone Followed by Long-Term Treatment With Interferon-beta1b

NCT00219908 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT00219908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00219908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis: Induction Treatment With Mitoxantrone Followed by Long-Term Treatment With Interferon-beta1b
Lead sponsor
Rennes University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 1999
Completion date
June 30, 2006
Enrollment
124
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis